A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

NCT04009876 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer (LARC)

Interventions

DRUG: nal-IRI
PROCEDURE: Surgical resection
OTHER: Watch-and-wait
DRUG: 5-FU/LV
DRUG: Oxaliplatin

Sponsor

Fundación de investigación HM

Collaborators

[object Object]